Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cabozantinib in medullary thyroid carcinoma: time to focus the spotlight on this rare disease.

Houvras Y, Wirth LJ. Cabozantinib in medullary thyroid carcinoma: time to focus the spotlight on this rare disease. J Clin Oncol. 2011 Jul 01; 29(19):2616-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.